Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

somatuline/suramin

Known as: Somatuline/SUR, Suramin/Somatuline 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Purpose Evaluate patients’ and nurses’ experiences, including injection problem frequency, with the somatostatin analogues (SSAs… Expand
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 2
Review
2016
Review
2016
Acromegaly is a hormonal disorder that arises when the pituitary gland secretes excess growth hormone (GH), which in turn… Expand
Highly Cited
2014
Highly Cited
2014
BACKGROUND Many patients with acromegaly do not achieve biochemical control despite receiving high doses of the first-generation… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
2012
2012
Background Long-acting somatostatin receptor ligands (SRL) with product-specific formulation and means of administration are… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
2012
2012
Lanreotide Autogel® (ATG) [Somatuline® Depot]1 is a novel, long-acting preparation of the somatostatin analog lanreotide acetate… Expand
2011
2011
BUDGET IMPACT ANALYSIS OF SOMATULINE AUTOGEL IN THE MANAGEMENT OF ACROMEGALY IN SPAIN Brosa M1, Betoret I2, Tapias G2 1Oblikue… Expand
Review
2002
Review
2002
Somatuline Autogel provides effective control of growth hormone levels and is at least as effective as intramuscular Somatuline… Expand
2002
2002
Le lanreotide Autogel® est une nouvelle forme galenique du lanreotide administree mensuellement par voie sous-cutanee profonde… Expand
  • table I
  • figure 1
  • table II
  • table III
Highly Cited
1997
Highly Cited
1997
Octreotide, a potent synthetic somatostatin (SM) analogue, was recently evaluated and found to have a beneficial effect in… Expand